Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cosmos Health Inc
(NQ:
COSM
)
0.6500
+0.1331 (+25.75%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
473,548
Open
0.5050
Bid (Size)
0.6400 (15)
Ask (Size)
0.6466 (63)
Prev. Close
0.5169
Today's Range
0.5050 - 0.6900
52wk Range
0.4677 - 4.050
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
April 19, 2024
Via
ACCESSWIRE
Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform
March 21, 2024
Via
ACCESSWIRE
Performance
YTD
-52.55%
-52.55%
1 Month
-8.42%
-8.42%
3 Month
-38.10%
-38.10%
6 Month
-35.00%
-35.00%
1 Year
-81.89%
-81.89%
More News
Read More
Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market
March 19, 2024
Via
ACCESSWIRE
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders
March 18, 2024
Via
ACCESSWIRE
Cosmos Health Successfully Completes Acquisition of Pharmatrade’s Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million
February 29, 2024
Via
ACCESSWIRE
Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying
February 22, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Taglich Brothers Publishes First Coverage Report on Cosmos Health with a Price Target of $4, a Nearly Five-Fold Increase from Current Share Price
February 21, 2024
Via
ACCESSWIRE
Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company
February 20, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 07, 2024
Via
Benzinga
Taglich Brothers Initiates Coverage of Cosmos Health Inc.
February 01, 2024
Via
ACCESSWIRE
Cosmos Health Completes Acquisition of Cloudscreen, a Cutting-Edge AI Platform; Enters Lucrative $25Bn+ Global Drug Repurposing Market
January 23, 2024
Via
ACCESSWIRE
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio
January 18, 2024
Via
ACCESSWIRE
Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023
December 27, 2023
Via
ACCESSWIRE
Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X
December 20, 2023
Via
ACCESSWIRE
Cosmos Health Announces Open Market Stock Purchases by the CEO
December 18, 2023
Via
ACCESSWIRE
Cosmos Health to Participate at Capital Link’s 'Invest in Greece' Forum in New York
December 08, 2023
Via
ACCESSWIRE
Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers
December 07, 2023
Via
ACCESSWIRE
Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product
December 01, 2023
Via
ACCESSWIRE
Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/Share
November 21, 2023
Via
ACCESSWIRE
Over $5M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying
October 13, 2023
Via
Benzinga
Cosmos Health to Acquire Cloudscreen, a Cutting-Edge AI-Powered Drug Repurposing Platform; Anticipated to Establish Cosmos as a Leader in the $25Bn Global Market and Deliver Unparalleled Returns for Shareholders
October 11, 2023
Via
ACCESSWIRE
COSMOS HEALTH CEO Issues Letter to Shareholders
October 05, 2023
Via
ACCESSWIRE
Ticking Time Bombs: 3 Healthcare Stocks to Dump Before the Damage Is Done
September 28, 2023
Via
InvestorPlace
Cosmos Health Actively Exploring Spinoff of R&D Division into a Publicly Listed Standalone Biotech Company
September 27, 2023
Via
ACCESSWIRE
Cosmos Health Announces Expansion of Its C-Sept Brand with the Launch of C-Scrub Wash; Capitalizing on $29 Billion Global Antiseptic and Disinfectant Market
September 26, 2023
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.